Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01905722 · ClinicalTrials.gov registry record · NA
Development of Novel Therapies for NIDDM
A NA study of Metabolism, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT01905722 is a NA study of Metabolism that has completed, run by Duke University. The registered enrollment target is 64 participants, below the 13,262-participant average among 19 other Metabolism trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01905722, a NA study of Metabolism, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of this program project grant is the development of technologies that lead to new methods for studying, detecting, and treating type 2 diabetes, and their integration with hypothesis-driven diabetes research projects. Project 4 of the grant, led by Dr. Craig Malloy at UTSW, will develop and apply new technology in MRI to test core hypotheses about the development of insulin resistance in people. The long-term goal is to develop technology to monitor metabolism in skeletal muscle, brain and the liver using magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) in a 3 Tesla and 7 Tesla MRI scanners. These advanced imaging methods allow researchers to take pictures of the inside of the body and to measure metabolism as it occurs in the MRI scanner. Standard clinical MRI for medical diagnosis and treatment is performed in a 1 Tesla or 3 Tesla MRI scanner. A primary goal of the 7 Tesla research program is to develop a group of protocols for investigating specific metabolic pathways in adipose (fat) tissue, skeletal muscle and the liver. This study is being done to improve methods of imaging and measuring molecules in a 3 Tesla or 7 Tesla scanners.
Conditions Studied
Interventions
- OTHER 3 Tesla
- OTHER 7 Tesla
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2013-12-10 |
| Est. Completion | 2017-05-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01905722
The ClinicalTrials.gov registry entry for NCT01905722 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 13,262-participant average among 19 other Metabolism trials with a reported enrollment target (100% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Metabolism appearing as the primary indexed condition, and to 2 interventions - of which 3 Tesla is the first listed.
NCT01905722 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01905722 about?
NCT01905722 is a clinical study titled "Development of Novel Therapies for NIDDM". The overarching goal of this program project grant is the development of technologies that lead to new methods for studying, detecting, and treating type 2 diabetes, and their integration with hypothesis-driven diabetes research projects. Project 4 of the grant, led by Dr. Craig Malloy at UTSW, wil...
What is the current status of trial NCT01905722?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2013-12-10. Estimated completion is 2017-05-17.
What conditions does trial NCT01905722 study?
This clinical trial studies the following conditions: Metabolism.
What interventions are being tested in trial NCT01905722?
The interventions under investigation include: 3 Tesla (OTHER), 7 Tesla (OTHER).
Who is sponsoring clinical trial NCT01905722?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01905722 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women
RECRUITING · NA
-
Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells
RECRUITING · NA
-
Personalized Responses to Dietary Composition Trial 3
RECRUITING · NA
-
Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS
ACTIVE NOT RECRUITING · NA
-
Duration of Physical Inactivity and Postprandial Lipid Metabolism
COMPLETED · NA
-
Effects of a Caffeine- and Protein-Containing Coffee Beverage on Metabolism and Muscular Performance
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.